Home > Insider Trading > Immutep Ltd > Profile

Immutep Ltd (IMMP)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

13F filing is ongoing

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2025, 5:34pm based on SEC 13F filings Last update: November 14, 2025, 5:34pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Millennium Management Israel Englander	49,297	$86,270		0%
2.	Citadel Investment Group Ken Griffin	44,072	$77,126		0%
3.	Citadel Investment GroupPUT Ken Griffin	11,000	$19,250	-60%	0%
4.	Citadel Investment GroupCALL Ken Griffin	0	$0		0%

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Blackrock, Inc.	580,444	$1,015,777	0%
2.	Meridian Wealth Management, Llc	420,900	$736,575	0.03%
3.	Sender Co & Partners, Inc.	215,861	$377,757	0.04%
4.	Morgan Stanley	165,966	$290,440	0%
5.	Sender Co & Partners, Inc.CALL	138,200	$241,850	0.03%

News See All

Immutep (IMMP) Scores Win After Announcing Deal With Indian Firm

Immutep Limited (NASDAQ:IMMP) is a biotechnology company developing therapies for cancer and autoimmune diseases. The firm’s shares underwent notable traction earlier this week after Indian firm Dr.

Keep Reading →

December 15th, 2025 - News

7 Best ASX Stocks to Buy Right Now

While the Federal Reserve cut interest rates in the US a couple of days back, in Australia, the trend appears to be moving in the opposite direction.

Keep Reading →

December 14th, 2025 - News

Immutep Limited (IMMP): Firm Reports Positive Data from Trials

In mid-November, Immutep Limited (NASDAQ:IMMP) reported positive data from two clinical trials of its drug candidate eftilagimod alpha, or efti.

Keep Reading →

December 10th, 2025 - News

11 Best Micro-Cap Stocks to Invest in According to Analysts

Micro-cap companies, generally referring to publicly traded businesses with less than $300 million in market capitalization, are among the most volatile and high-risk investments in the stock market.

Keep Reading →

December 9th, 2025 - Hedge Funds News

Immutep Limited (IMMP) Receives Positive FDA Feedback on Future Clinical Development of Eftilagimod Alfa

Immutep Limited (NASDAQ:IMMP) is among the 12 Best Australian Stocks to Buy Right Now. On August 5, the company shared that it had received positive feedback from the U.S.

Keep Reading →

August 17th, 2025 - News

12 Best Australian Stocks to Buy Right Now

Australia’s S&P/ASX 200 index advanced 0.53% on Thursday to close at 8,873.80, with investors buoyed by gains in the banking sector, amid robust earnings and renewed hopes for further interest rate ...

Keep Reading →

August 15th, 2025 - Hedge Funds News

Immutep (IMMP) Announces Positive Initial Efficacy Data and Continued Favourable Safety Data

Immutep Limited (NASDAQ:IMMP) is one of the 7 Best ASX Stocks to Buy Now.

Keep Reading →

June 29th, 2025 - News

7 Best ASX Stocks to Buy Now

While the Australian market is relatively well-positioned, it is vulnerable to broader market shocks, says SG Hiscock & Company (an Australian boutique investment manager).

Keep Reading →

June 28th, 2025 - Hedge Funds News